CA2249348A1 - Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide - Google Patents

Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide

Info

Publication number
CA2249348A1
CA2249348A1 CA002249348A CA2249348A CA2249348A1 CA 2249348 A1 CA2249348 A1 CA 2249348A1 CA 002249348 A CA002249348 A CA 002249348A CA 2249348 A CA2249348 A CA 2249348A CA 2249348 A1 CA2249348 A1 CA 2249348A1
Authority
CA
Canada
Prior art keywords
trifluoromethylphenyl
trifluoromethyl
cyano
combination
methylisoxazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002249348A
Other languages
French (fr)
Other versions
CA2249348C (en
Inventor
Robert Bartlett
Johann Then
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19610955A external-priority patent/DE19610955A1/en
Application filed by Individual filed Critical Individual
Publication of CA2249348A1 publication Critical patent/CA2249348A1/en
Application granted granted Critical
Publication of CA2249348C publication Critical patent/CA2249348C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Combination preparation, comprising 5-methyl-4'-trifluoromethyl-4-isoxazolecarboxanilide and N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide A solid preparation, comprising 5-methyl-4'-trifluoromethyl-4-isoxazolecarboxanilide and N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide is suitable for treating immunological diseases.
CA002249348A 1996-03-20 1997-03-07 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide Expired - Lifetime CA2249348C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19610955.8 1996-03-20
DE19610955A DE19610955A1 (en) 1996-03-20 1996-03-20 Combination preparation containing 5-methylisoxazole-4-carboxylic acid- (4-trifluoromethyl) -anilide and N- (4-trifluoromethylphenyl) -2-cyano-3-hydroxycrotonic acid amide
PCT/EP1997/001167 WO1997034600A1 (en) 1996-03-20 1997-03-07 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide

Publications (2)

Publication Number Publication Date
CA2249348A1 true CA2249348A1 (en) 1997-09-25
CA2249348C CA2249348C (en) 2006-10-03

Family

ID=37101799

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002249348A Expired - Lifetime CA2249348C (en) 1996-03-20 1997-03-07 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide

Country Status (1)

Country Link
CA (1) CA2249348C (en)

Also Published As

Publication number Publication date
CA2249348C (en) 2006-10-03

Similar Documents

Publication Publication Date Title
AU1926197A (en) Preparation containing a combination of 5-methylisoxazole-4 -carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide
EP0906310A4 (en) OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE -g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY
IL94348A0 (en) Fungicidal agents,comprising substituted amino acid amide derivatives,certain such novel derivatives and their preparation
AU4027193A (en) High performance VPO catalyst and process of preparation thereof
FR2744442B1 (en) PREPARATION OF 1,1,1,3,3-PENTACHLOROBUTANE AND 1,1,1,3,3, -PENTAFLUOROBUTANE
IL125671A0 (en) Crystal form of n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
EG20182A (en) Derivatives of 4- benzoyl isoxazole derivatives used as herbicides
AU9307098A (en) Spiro{pyrrolidine-2,3'-oxindole} compounds and methods of use
AR242561A1 (en) Procedure for the preparation of s-(-)-1-propyl-2',6'-pipecoloxylidide hydrochloride that is substantially pure, and the procedure involved.
AU4018897A (en) Novel 3,4-diaryloxazolone derivatives, methods of preparation and therapeutic uses thereof
AU4378297A (en) Preparation of amines and aminonitriles
IT1272924B (en) PROCEDURE FOR THE PREPARATION OF CYCLOPENTADIENYL COMPOUNDS AND COMPOUNDS SO OBTAINABLE
PL314745A1 (en) Derivatives of n-[(1,4-diazabicyclo[2.2.2]-oct-2-ylo)methyl]benzamide and method of obtaining them
CA2249348A1 (en) Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide
AU607250B2 (en) Benzenesulfonyl carboxamide compounds, intermediate compounds and methods of preparation thereof and use of said compounds and intermediate compounds as herbicidal agents
PL322367A1 (en) Stable solid preparations of cyclohexanone oxymonoether type herbicides
SI0896537T1 (en) Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide
JPS6416755A (en) Manufacture of n-(3',4'-dimethoxycinnamoyl)-aniline derivative
IL85350A0 (en) Acaricidal agents comprising azomethines of 2,3-diaminomaleic acid nitrile,certain such novel compounds and their preparation
ZA961346B (en) Process for the preparation of oxazolidinones novel oxazolidinones and the use of oxazolidinones
AU7358896A (en) 1-{4-(4'-sulfanilyl)phenyl}urea and derivatives for the treatment of leishmaniasis
AU2076195A (en) Novel 3-(omega-(4-benzoylpiperidino)alkyl)-4h-benzopyran-4-ones, preparation and therapeutical use thereof
AU645041B2 (en) N-(3',4'-dimethoxycinnamoyl)anthranilic acid
CS72588A1 (en) Substituted n-(2,6-dialkyl phenyl)n-arene sulphonyl urea and method of their preparation
GB9221096D0 (en) Improved photoresist chemical,method of preparation of same and photoresist prepared therefrom

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170307